MindBio is a biotechnology company targeting depressive and other illnesses through research, clinical trials and innovative technology development.  MindBio develops prediction tools for optimising health and wellness.  MindBio has completed world leading research and multiple clinical trials in microdosing of psychedelic medicines over the past 5 years.   The Company's drug and alcohol research has led to the creation of a world first prediction tool using the human voice and AI to estimate blood alcohol concentration over a smartphone.  MindBio's technological innovations are primarily aimed at preventing unnecessary illness, injury and harm and the company's work is geared towards improving and enhancing health and wellness.